Advanced Filters
noise

Minatoga, Japan Clinical Trials

A listing of Minatoga, Japan clinical trials actively recruiting patients volunteers.

Found 64,778 clinical trials
F For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)

Patient-Centered Assessment of Symptoms and Outcomes

Background The cause of fatigue is not well understood. It can be felt differently by different people. Some people think there are different types of fatigue, with different causes. Researchers think a therapy to treat one type of fatigue in one condition should be able to treat that type of …

18 years of age All Phase N/A
J Jenny Poynter, PhD

Molecular Epidemiology of Pediatric Germ Cell Tumors

A Non-Therapeutic Study that aims to establish a cohort of GCT survivors to understand short term and long-term adverse effects of treatment and to conduct molecular analyses to improve risk stratification.

years of age All Phase N/A
N Natalie Carroll

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with microscopic hematuria.

18 - 90 years of age All Phase N/A
P Pallavi Huma Arya

Public Survey on Breath Testing for Health and Disease

A brief survey for the public to determine interest in health surveillance and disease detection

18 years of age All Phase N/A

Genome Medical Sequencing for Genome Discovery

Background A number of rare inherited diseases affect only a few patients, and the genetic causes of these conditions remain unknown. Researchers are studying the use of a new technology called genome sequencing to learn which gene or genes cause these conditions. Understanding the genes that cause these diseases is …

4 - 99 years of age All Phase N/A
S Susanne Walitza, Prof. Dr. med. Dipl.-Psych.

Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood

Obsessive-compulsive disorders are very damaging illnesses that can already manifest in childhood and adolescence. With an average prevalence from 1 - 3%, they are one of the most frequently diagnosed psychiatric illness in these age groups. With the further use of data, the treatment success can be significantly improved; causal …

4 - 18 years of age All Phase N/A
C Chloe S Zimmerman, MD/PhD Student

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

This study relies on the use of a smartphone application (SOMA) that the investigators developed for tracking daily mood, pain, and activity status in acute pain, chronic pain, and healthy controls over four months.The primary goal of the study is to use fluctuations in daily self-reported symptoms to identify computational …

18 years of age All Phase N/A
Y Yi Han, doctorate

Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With Acute and Advanced Heart Failure With Renal Insufficiency

To evaluate the efficacy and safety of levosimendan and milrinone in the treatment of with acute heart failure with or without renal dysfunction; Predictive modeling of the efficacy and safety of levosimendan and milrinone.

18 - 80 years of age All Phase N/A
J Jean Ferrières, PU-PH

Identification of New Biomarkers for the Prediction of Cardiovascular Events

The main goal of this project is to constitute a collection of biological samples, obtained through the clinical activity of the Centre for Screening and Prevention of Atherosclerosis at Toulouse University Hospital, managing patients in primary or secondary prevention for cardiovascular (CV) diseases. The main objective is to validate new …

18 - 99 years of age All Phase N/A
K Krzysztof Dyrbus

Hyperlipidemia Therapy TERCET Zabrze Registry

A study conducted to evaluate the efficacy of lipid-lowering therapy in patients with high and very high risk treated by interventional cardiology. Study endpoints: Achievement of the target LDL-C at 1-year follow-up LDL-C <70 mg / dl in the group of very high-risk and LDL-C <100 mg / dL in …

18 years of age All Phase N/A

Simplify language using AI